Bebbington, P, McGuffin, P (1988). Schizophrenia: The Major Issues. Heinemann & Mental Health Foundation: Oxford, England.
Donohoe, G, Dillon, R, Hargreaves, A, Mothersill, O, Castorina, M, Furey, E, Fagan, AJ, Meaney, JF, Fitzmaurice, B, Hallahan, B, McDonald, C, Wykes, T, Corvin, A, Robertson, IH (2018). Effectiveness of a low support, remotely accessible, cognitive remediation training programme for chronic psychosis: cognitive, functional and cortical outcomes from a single blind randomised controlled trial. Psychological Medicine 48, 751–764.
Emsell, L, Leemans, A, Langan, C, Van Hecke, W, Barker, GJ, McCarthy, P, Jeurissen, B, Sijbers, J, Sunaert, S, Cannon, DM, McDonald, C (2013). Limbic and callosal white matter changes in euthymic bipolar I disorder: an advanced diffusion MRI tractography study. Biological Psychiatry 73, 194–201.
English, JA, Lopez, LM, O’Gorman, A, Föcking, M, Hryniewiecka, M, Scaife, C, Sabherwal, S, Wynne, K, Dicker, P, Rutten, BPF, Lewis, G, Zammit, S, Cannon, M, Cagney, G, Cotter, DR (2018). Blood-based protein changes in childhood are associated with increased risk for later psychotic disorder: evidence from a Nested Case-Control Study of the ALSPAC Longitudinal Birth Cohort. Schizophrenia Bulletin 44, 297–306.
Föcking, F, Sabherwal, S, Cates, HM, Scaife, C, Dicker, P, Hryniewiecka, M, Wynne, K, Rutten, BPF, Lewis, G, Cannon, M, Nestler, EJ, Heurich, M, Cagney, G, Zammit, S, Cotter, DR (in press). Complement pathway changes at age 12 are associated with the psychotic experiences at age 18: evidence from the ALSPAC birth cohort. Molecular Psychiatry PMID: 30635638.
Girgis, RR, Zoghbi, AW, Javitt, DC, Lieberman, JA (2019). The past and future of novel, non-dopamine-2 receptor therapeutics for schizophrenia: a critical and comprehensive review. Journal of Psychiatric Research 108, 57–83.
Kelleher, I, Corcoran, P, Keeley, H, Wigman, JTW, Devlin, N, Ramsay, H, Wasserman, C, Carli, V, Sarchiapone, M, Hoven, C, Wasserman, D, Cannon, M (2013). Psychotic symptoms and population risk for suicide attempt: a prospective cohort study. JAMA Psychiatry 70, 940–948.
Kincaid, D, Shannon, C, Boyd, A, Hanna, D, McNeill, O, Anderson, R, Francis-Naylor, M, Mulholland, C (2018). An investigation of associations between experience of childhood trauma and political violence and theory of mind impairments in schizophrenia. Psychiatry Research 270, 293–297.
Madrid-Gambin, F, Föcking, M, Sabherwal, S, Heurich, M, English, J, O’Gorman, A, Suvitaival, T, Cannon, M, Lewis, G, Mattila, I, Scaife, C, Madden, S, Hyötyläinen, T, Orešič, M, Zammit, S, Cagney, G, Cotter, DR, Brennan, L (2019). Integrated lipidomics and proteomics point to early blood-based changes in childhood preceding later development of psychotic experiences: evidence from the Avon Longitudinal Study of Parents and Children. Biological Psychiatry 86, 25–34.
McCarthy, SE, McCombie, WR, Corvin, A (2014). Unlocking the treasure trove: from genes to schizophrenia biology. Schizophrenia Bulletin 40, 492–496.
Mothersill, D, Dillon, R, Hargreaves, A, Castorina, M, Furey, E, Fagan, AJ, Meaney, JF, Fitzmaurice, B, Hallahan, B, McDonald, C, Wykes, T, Corvin, A, Robertson, IH, Donohoe, G (2018). Computerised working memory-based cognitive remediation therapy does not affect Reading the Mind in the Eyes test performance or neural activity during a Facial Emotion Recognition test in psychosis. European Journal of Neuroscience 48, 1691–1705. doi:10.1111/ejn.13976
O’Donoghue, B, Lyne, J, Madigan, K, Lane, A, Turner, N, O’Callaghan, E, Clarke, M (2015). Environmental factors and the age at onset in first episode psychosis. Schizophrenia Research 168, 106–112.